Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".

Response to letter regarding article, "warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (birmingham atrial fibrillation treatment of the aged study)".

Manylion Llyfryddiaeth
Prif Awduron:	Mavaddat, N, Roalfe, A, Fletcher, K, Lip, G, Hobbs, R, Fitzmaurice, D, Mant, J
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2014

Eitemau Tebyg

Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial (Birmingham Atrial Fibrillation Treatment of the Aged Study).
gan: Mavaddat, N, et al.
Cyhoeddwyd: (2014)

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
gan: Mant, J, et al.
Cyhoeddwyd: (2007)

Warfarin versus aspirin for prevention of cognitive decline in an elderly community population with atrial fibrillation (the BAFTA Study): a randomised controlled trial
gan: Mavaddat, N, et al.
Cyhoeddwyd: (2013)

Cost effectiveness of warfarin versus aspirin in patients older than 75 years with atrial fibrillation.
gan: Jowett, S, et al.
Cyhoeddwyd: (2011)

Is warfarin a safe alternative to aspirin in elderly patients with atrial fibrillation?
gan: Mant, J, et al.
Cyhoeddwyd: (2008)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
gan: Mant, J, et al.
Cyhoeddwyd: (2003)

Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
gan: Fletcher Kate, et al.
Cyhoeddwyd: (2003-08-01)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
gan: Hobbs, F, et al.
Cyhoeddwyd: (2011)

Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial
gan: Hobbs, R, et al.
Cyhoeddwyd: (2011)

A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.
gan: Roalfe, A, et al.
Cyhoeddwyd: (2012)

Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project.
gan: Farhan Shahid, et al.
Cyhoeddwyd: (2018-01-01)

A cross-sectional study of hypertension in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation in the Aged (BAFTA) randomised controlled trial.
gan: Hurley, V, et al.
Cyhoeddwyd: (2007)

Impact of study design on recruitment of patients to a primary care trial: an observational time series analysis of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study.
gan: Fletcher, K, et al.
Cyhoeddwyd: (2010)

Warfarin versus aspirin for stroke prevention (BAFTA) - Reply
gan: Mant, J, et al.
Cyhoeddwyd: (2007)

The use of warfarin in veterans with atrial fibrillation
gan: Rosenbeck Karen, et al.
Cyhoeddwyd: (2004-10-01)

Anticoagulant management in patients with atrial fibrillation.
gan: Fitzmaurice, D, et al.
Cyhoeddwyd: (2009)

Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial.
gan: Mant, J, et al.
Cyhoeddwyd: (2007)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
gan: I. Yu. Koroleva, et al.
Cyhoeddwyd: (2016-11-01)

Research into practice: management of atrial fibrillation in general practice.
gan: Fitzmaurice, D, et al.
Cyhoeddwyd: (2014)

Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial
gan: Chan-Hyuk Lee, et al.
Cyhoeddwyd: (2019-05-01)

Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
gan: Line Melgaard, et al.
Cyhoeddwyd: (2021-12-01)

Alcohol and Atrial Fibrillation
gan: Stanisław Surma, et al.
Cyhoeddwyd: (2023-03-01)

Should we screen for atrial fibrillation?
gan: Lown, M, et al.
Cyhoeddwyd: (2017)

Atrial Fibrillation-Related Outcomes [Letter]
gan: Naser A
Cyhoeddwyd: (2024-10-01)

Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
gan: Jean Michell Correia Monteiro, et al.

The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.
gan: Bungard, T, et al.
Cyhoeddwyd: (2003)

CAN CLOPIDOGREL FULLY SUBSTITUTE WARFARIN AND DABIGATRAN IN ATRIAL FIBRILLATION?
gan: A. B. Sumarokov
Cyhoeddwyd: (2013-08-01)

Warfarin and its role in the prevention of thromboembolism in atrial fibrillation (lecture)
gan: Y. V. Shubik
Cyhoeddwyd: (2015-12-01)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
gan: Carolina eMalta Hansen, et al.
Cyhoeddwyd: (2012-06-01)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
gan: Sana Rashid, et al.
Cyhoeddwyd: (2021-12-01)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
gan: Touchette DR,, et al.
Cyhoeddwyd: (2008-03-01)

ANTICOAGULATION IN PATIENTS WITH ATRIAL-FIBRILLATION - EXPERT SOFTWARE MAY BE THE ANSWER
gan: Fitzmaurice, D, et al.
Cyhoeddwyd: (1994)

Management of atrial fibrillation
gan: Puneet Kakar, et al.
Cyhoeddwyd: (2007-03-01)

Identifying At‐Risk Patients for Sustained Atrial High‐Rate Episodes Using the C2HEST Score: The West Birmingham Atrial Fibrillation Project
gan: Yan‐Guang Li, et al.
Cyhoeddwyd: (2021-03-01)

SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS
gan: E. L. Artanova, et al.
Cyhoeddwyd: (2016-01-01)

Prevalence of atrial fibrillation in the general population and in high-risk groups: The ECHOES study
gan: Davis, R, et al.
Cyhoeddwyd: (2012)

Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study.
gan: Davis, R, et al.
Cyhoeddwyd: (2012)

Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.
gan: van Walraven, C, et al.
Cyhoeddwyd: (2009)

Stroke prevention in atrial fibrillation
gan: Hobbs, F
Cyhoeddwyd: (2003)

Patients with Atrial Fibrillation are Unlikely to Benefit from Aspirin Monotherapy
gan: Wang N, et al.
Cyhoeddwyd: (2024-05-01)